Why the VA’s health arm will cover a new Alzheimer’s drug ... and Medicare won’t
The Veterans Health Administration announced earlier this week that it will cover Leqembi, a new Alzheimer’s drug that appears to slow the disease’s progression. Host Megan Messerly talks with Katherine Ellen Foley about why the VHA’s decision differs from other federal agencies.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Veterans Health Administration announced earlier this week that it will cover Leqembi, a new Alzheimer’s drug that appears to slow the disease’s progression. Host Megan Messerly talks with Katherine Ellen Foley about why the VHA’s decision differs from other federal agencies.
Learn more about your ad choices. Visit megaphone.fm/adchoices